• Prostate cancer risk, screening and management in patients with germline BRCA1/2 mutations.
• Rajwa P, Quhal F, Pradere B, Gandaglia G, Ploussard G, Leapman MS, Gore JL, Paradysz A, Tilki D, Merseburger AS, Morgan TM, Briganti A, Palapattu GS, Shariat SF.
• Nat Rev Urol. 2023 Jan 4. doi: 10.1038/s41585-022-00680-4. Epub ahead of print.

• PMID: 36600087
• PubMed abstract
• Source abstract

• Review